• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单基因糖尿病:诊断的新老方法。

Monogenic diabetes: old and new approaches to diagnosis.

机构信息

University of Oxford, Oxford, UK.

出版信息

Clin Med (Lond). 2013 Jun;13(3):278-81. doi: 10.7861/clinmedicine.13-3-278.

DOI:10.7861/clinmedicine.13-3-278
PMID:23760703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5922673/
Abstract

Up to 5% of young adults diagnosed with diabetes have a monogenic aetiology, the most common of which is maturity-onset diabetes of the young (MODY). A definitive molecular diagnosis is important, as this affects treatment, prognosis and family screening. Currently, however, rates of diagnosis are low due to a combination of lack of awareness of the benefits of making the diagnosis and the challenges of differentiating patients with MODY from those with common forms of diabetes. This article aims to introduce general physicians to the characteristics of monogenic diabetes and the clinical features that can be used to diagnose patients. Recently, genomewide association studies have resulted in the identification of C-reactive protein and glycan profile as specific biomarkers for the most common MODY subtype due to HNF1A mutations, and the potential translation of these findings are discussed.

摘要

高达 5%的年轻成人糖尿病患者存在单基因病因,最常见的是青少年发病的成年型糖尿病(MODY)。明确的分子诊断很重要,因为这会影响治疗、预后和家族筛查。然而,由于缺乏对诊断益处的认识以及区分 MODY 患者与常见糖尿病形式的挑战,目前的诊断率仍然很低。本文旨在向全科医生介绍单基因糖尿病的特征以及可用于诊断患者的临床特征。最近,全基因组关联研究导致了 C 反应蛋白和聚糖谱的鉴定,这些标志物是由于 HNF1A 突变导致的最常见 MODY 亚型的特异性生物标志物,并且讨论了这些发现的潜在转化。

相似文献

1
Monogenic diabetes: old and new approaches to diagnosis.单基因糖尿病:诊断的新老方法。
Clin Med (Lond). 2013 Jun;13(3):278-81. doi: 10.7861/clinmedicine.13-3-278.
2
RD Lawrence lecture 2012: assessing aetiology in diabetes: how C-peptide, CRP and fucosylation came to the party!RD 劳伦斯讲座 2012:评估糖尿病病因学:C 肽、CRP 和岩藻糖化如何参与其中!
Diabet Med. 2013 Mar;30(3):260-6. doi: 10.1111/dme.12038.
3
Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.评估高敏 C 反应蛋白水平作为 HNF1A 基因突变导致的青年发病成年型糖尿病的诊断鉴别指标。
Diabetes Care. 2010 Sep;33(9):1919-24. doi: 10.2337/dc10-0288. Epub 2010 Aug 19.
4
A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.一种用于识别因 HNF1A 突变而患有单基因糖尿病高概率患者的决策算法。
Endocrine. 2019 Apr;64(1):75-81. doi: 10.1007/s12020-019-01863-7. Epub 2019 Feb 18.
5
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.一项大型多中心欧洲研究证实了高敏 C 反应蛋白 (hsCRP) 作为糖尿病亚型诊断的临床生物标志物的有效性。
Diabetologia. 2011 Nov;54(11):2801-10. doi: 10.1007/s00125-011-2261-y. Epub 2011 Aug 4.
6
Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.在诊断为 1 型糖尿病的土耳其儿童队列中,由于葡萄糖激酶、HNF1-A、HNF1-B 和 HNF4-A 突变导致的青少年发病的成年型糖尿病。
Horm Res Paediatr. 2018;90(4):257-265. doi: 10.1159/000494431. Epub 2018 Nov 27.
7
Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.对临床诊断为 2 型年轻起病糖尿病的成人进行病因学系统评估是识别青年发病的成年型糖尿病的成功策略。
Diabetes Care. 2012 Jun;35(6):1206-12. doi: 10.2337/dc11-1243. Epub 2012 Mar 19.
8
Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.尿 C 肽肌酐比值是一种实用的门诊工具,可用于从长病程 1 型糖尿病中识别肝细胞核因子 1-α/肝细胞核因子 4-α 成年起病的青年型糖尿病。
Diabetes Care. 2011 Feb;34(2):286-91. doi: 10.2337/dc10-1293.
9
HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.高密度脂蛋白胆固醇作为儿童和青年人群中 GCK-MODY 与 HNF1A-MODY 及 1 型糖尿病临床鉴别诊断的工具。
Clin Endocrinol (Oxf). 2011 Sep;75(3):321-7. doi: 10.1111/j.1365-2265.2011.04052.x.
10
Mutations in HNF1A result in marked alterations of plasma glycan profile.HNF1A 基因突变导致血浆聚糖谱明显改变。
Diabetes. 2013 Apr;62(4):1329-37. doi: 10.2337/db12-0880. Epub 2012 Dec 28.

引用本文的文献

1
Monogenic diabetes: An evidence-based clinical approach.单基因糖尿病:基于证据的临床方法。
World J Diabetes. 2025 May 15;16(5):104787. doi: 10.4239/wjd.v16.i5.104787.
2
Genetic perspectives on childhood monogenic diabetes: Diagnosis, management, and future directions.儿童单基因糖尿病的遗传学观点:诊断、管理及未来方向
World J Diabetes. 2023 Dec 15;14(12):1738-1753. doi: 10.4239/wjd.v14.i12.1738.
3
C-peptide and residual β-cell function in pediatric diabetes - state of the art.儿科糖尿病中的 C 肽和残余β细胞功能 - 最新进展。
Pediatr Endocrinol Diabetes Metab. 2021;27(2):123-133. doi: 10.5114/pedm.2021.107165.
4
Maturity onset diabetes of the young and fibrin-related thrombosis risk.青年发病型糖尿病与纤维蛋白相关血栓形成风险。
Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120963048. doi: 10.1177/1479164120963048.
5
Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives.青少年发病的成年型糖尿病的基因检测:现状与未来展望
Front Endocrinol (Lausanne). 2018 May 17;9:253. doi: 10.3389/fendo.2018.00253. eCollection 2018.
6
Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?生物标志物能否帮助确定抗体阴性糖尿病中的青少年发病的成年型糖尿病的遗传检测靶点?
Diabetes Technol Ther. 2018 Feb;20(2):106-112. doi: 10.1089/dia.2017.0317.
7
Comprehensive Maturity Onset Diabetes of the Young (MODY) Gene Screening in Pregnant Women with Diabetes in India.印度糖尿病孕妇的青少年发病型成年糖尿病(MODY)基因综合筛查
PLoS One. 2017 Jan 17;12(1):e0168656. doi: 10.1371/journal.pone.0168656. eCollection 2017.
8
When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes.何时为青少年发病的成年型糖尿病?青少年发病的成年型糖尿病基因序列变异解读中的挑战。
Rev Diabet Stud. 2015 Fall-Winter;12(3-4):330-48. doi: 10.1900/RDS.2015.12.330. Epub 2016 Feb 10.
9
New insights from monogenic diabetes for "common" type 2 diabetes.单基因糖尿病为“常见”2型糖尿病带来的新见解。
Front Genet. 2015 Aug 7;6:251. doi: 10.3389/fgene.2015.00251. eCollection 2015.
10
Diabetic ketoacidosis in the setting of HNF1A-maturity onset diabetes of the young.伴有肝细胞核因子1A(HNF1A)-青年发病的成年型糖尿病的糖尿病酮症酸中毒
BMJ Case Rep. 2015 Apr 2;2015:bcr2014209163. doi: 10.1136/bcr-2014-209163.

本文引用的文献

1
Mutations in HNF1A result in marked alterations of plasma glycan profile.HNF1A 基因突变导致血浆聚糖谱明显改变。
Diabetes. 2013 Apr;62(4):1329-37. doi: 10.2337/db12-0880. Epub 2012 Dec 28.
2
Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.对临床诊断为 2 型年轻起病糖尿病的成人进行病因学系统评估是识别青年发病的成年型糖尿病的成功策略。
Diabetes Care. 2012 Jun;35(6):1206-12. doi: 10.2337/dc11-1243. Epub 2012 Mar 19.
3
Diagnosis and classification of diabetes mellitus.糖尿病的诊断与分类
Diabetes Care. 2012 Jan;35 Suppl 1(Suppl 1):S64-71. doi: 10.2337/dc12-s064.
4
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.一项大型多中心欧洲研究证实了高敏 C 反应蛋白 (hsCRP) 作为糖尿病亚型诊断的临床生物标志物的有效性。
Diabetologia. 2011 Nov;54(11):2801-10. doi: 10.1007/s00125-011-2261-y. Epub 2011 Aug 4.
5
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.高敏 C 反应蛋白可将 HNF1A-MODY 与其他类型糖尿病区分开来。
Diabetes Care. 2011 Aug;34(8):1860-2. doi: 10.2337/dc11-0323. Epub 2011 Jun 23.
6
Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene.因 HNF1A 基因突变导致的青年发病的成年型糖尿病(MODY)的临床特征和诊断标准。
J Clin Endocrinol Metab. 2011 Aug;96(8):E1346-51. doi: 10.1210/jc.2011-0268. Epub 2011 Jun 15.
7
Role of molecular genetics in transforming diagnosis of diabetes mellitus.分子遗传学在改变糖尿病诊断中的作用。
Expert Rev Mol Diagn. 2011 Apr;11(3):313-20. doi: 10.1586/erm.10.123.
8
Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.基因组学与糖组学相遇——人类 N-糖组学的首次 GWAS 研究鉴定 HNF1α 为血浆蛋白岩藻糖基化的主要调控因子。
PLoS Genet. 2010 Dec 23;6(12):e1001256. doi: 10.1371/journal.pgen.1001256.
9
Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.评估高敏 C 反应蛋白水平作为 HNF1A 基因突变导致的青年发病成年型糖尿病的诊断鉴别指标。
Diabetes Care. 2010 Sep;33(9):1919-24. doi: 10.2337/dc10-0288. Epub 2010 Aug 19.
10
Maturity-onset diabetes of the young (MODY): how many cases are we missing?青少年起病的成年型糖尿病(MODY):我们遗漏了多少病例?
Diabetologia. 2010 Dec;53(12):2504-8. doi: 10.1007/s00125-010-1799-4. Epub 2010 May 25.